Back to News
Market Impact: 0.5

How Will Bristol Myers Squibb Stock React To Its Upcoming Earnings?

BMYSOFI
Corporate EarningsCompany FundamentalsAnalyst EstimatesMarket Technicals & FlowsInvestor Sentiment & PositioningHealthcare & BiotechCorporate Guidance & OutlookDerivatives & Volatility
How Will Bristol Myers Squibb Stock React To Its Upcoming Earnings?

Bristol Myers Squibb (BMY) is scheduled to release its earnings on July 31, 2025, with consensus estimates at $1.10 EPS on $11.38 billion in sales, down from the prior year. Historically, BMY's one-day stock returns post-earnings have been evenly split over the last five years, showing a median gain of 2.0% in positive instances and a median decline of -3.4% in negative instances. This historical pattern, alongside potential correlations between short-term and medium-term returns, offers insights for event-driven trading strategies both pre- and post-earnings.

Analysis

Bristol Myers Squibb (BMY) faces a challenging outlook ahead of its July 31, 2025, earnings release, with consensus estimates projecting a significant year-over-year decline in performance. Forecasts anticipate earnings of $1.10 per share on $11.38 billion in sales, markedly lower than the $2.07 per share and $12.2 billion in sales reported in the prior-year quarter. Historical analysis of post-earnings stock reactions over the past five years reveals a neutral probability but an asymmetric risk profile; one-day returns have been positive in 50% of instances, but the median negative return of -3.4% is substantially larger than the median positive return of 2.0%. While a more recent three-year view shows a slight increase in the frequency of positive returns to 55%, the potential for larger downside moves remains a key consideration. The article suggests that event-driven strategies could be formulated based on this historical data, but the lack of provided correlation data between short-term and medium-term returns limits the immediate applicability of a post-announcement momentum trade.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo